Lexington, Kentucky 40536


Purpose:

This study will determine the initial efficacy of phendimetrazine as a pharmacotherapy for cocaine dependence. A rigorous, inpatient human laboratory study will be conducted in which the subjective, physiological and reinforcing effects of cocaine are evaluated during maintenance on placebo and phendimetrazine.


Criteria:

Inclusion Criteria: - Recent cocaine use Exclusion Criteria: - Abnormal screening outcome (e.g., ECG, blood chemistry result) that study physicians deem clinically significant - Current or past histories of substance abuse or dependence that are deemed by the study physicians to interfere with study completion - History of serious physical disease, current physical disease, impaired cardiovascular functioning, chronic obstructive pulmonary disease, history of seizure or current or past histories of serious psychiatric disorder that in the opinion of the study physician would interfere with study participation will be excluded from participation - Females not currently using effective birth control - Contraindications to cocaine or phendimetrazine


NCT ID:

NCT02522325


Primary Contact:

William W Stoops, Ph.D.
Phone: 859-257-5388
Email: william.stoops@uky.edu


Backup Contact:

N/A


Location Contact:

Lexington, Kentucky 40536
United States

William W Stoops, Ph.D.
Phone: 859-257-5388
Email: william.stoops@uky.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.